AF and Stroke Prevention

New data confirms that the Boston Scientific WATCHMAN™ Left Atrial Appendage Closure Device is safe and effective in reducing the risk of stroke in patients deemed unsuitable for oral anticoagulation - May 18, 2017

One-year data from the EWOLUTION registry found that left atrial appendage closure (LAAC) with the WATCHMAN™ device followed by dual antiplatelet therapy (DAPT) significantly...

Read more

New data from the EWOLUTION registry presented at EuroPCR 2016 confirms safety of the Boston Scientific WATCHMAN™ Left Atrial Appendage Closure device 

May 17, 2016

Three-months outcomes on more than 1000 patients across Europe focus on post-procedural drug regimen, impact of centre experience and peri-device leakage. 

Read more

SEE ALL PRESS RELEASES  

20162015 | 2014 | 2013 | 2012  

Media Contacts

Rosie Ireland
Corporate Communications
+44 7585403359
rosie.ireland@bsci.com

Company Profile
Top